Andere Sprachen Carmell Corporation

Aktien

A3ENXR

US1429221039

CTCX

Verzögert Nasdaq Andere Börsenplätze 15:30:00 10.06.2024			% 5 Tage	% 1. Jan.
2,5 ^USD	-2,34 %		-3,47 %	-34,38 %

15.05.	Carmell Corporation meldet Gewinnergebnisse für das erste Quartal bis zum 31. März 2024	CI
01.04.	Carmell Corporation meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Carmell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Carmell Announces Successful Closing of $3.0 Million Private Placement	11.04.
Carmell Corporation announced that it has received $3 million in funding	11.04.
Carmell Announces $3.0 Million Private Placement	04.04.
Carmell Corporation announced that it expects to receive $3 million in funding	04.04.
Carmell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	01.04.
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction	27.03.
An undisclosed buyer completed the acquisition of Axolotl Biologix, Inc. from Carmell Corporation.	26.03.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Fed Maintains Rate Cut Outlook	21.03.
Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket	21.03.
An undisclosed buyer entered into a a definitive agreement to acquire Axolotl Biologix, Inc. from Carmell Corporation ).	20.03.
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	26.02.
Carmell Corporation Announces Appointment of Dr. Bradley Calobrace to Scientific Advisory Board	17.01.
Carmell Corp Announces Appointment of Dr. Jason D. Bloom to Scientific Advisory Board	17.01.
Carmell Corporation Announces Appointment of Dr. Adam Rubinstein to Scientific Advisory Board	17.01.
Carmell Corporation Announces Appointment of Dr. Gregory A. Buford to Scientific Advisory Board	17.01.
Carmell Corporation Announces Appointment of Dr. Sean Kelishadi to Scientific Advisory Board	17.01.
Carmell Corporation Announces Addition of Two Independent Directors	16.11.
Carmell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15.11.
Carmell Therapeutics Corporation(NasdaqCM:CTCX) added to S&P TMI Index	18.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Carmell Corporation

Aktien

A3ENXR

US1429221039

CTCX

Andere Sprachen

Filter